Attached files
| file | filename |
|---|---|
| EX-32.1 - EX-32.1 - Neuronetics, Inc. | stim-ex321_11.htm |
| EX-31.2 - EX-31.2 - Neuronetics, Inc. | stim-ex312_14.htm |
| EX-31.1 - EX-31.1 - Neuronetics, Inc. | stim-ex311_8.htm |
| 10-Q - STIM-10Q-09.30.2020 - Neuronetics, Inc. | stim-10q_20200930.htm |
Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report on Form 10-Q of Neuronetics, Inc. (the “Company”) for the fiscal quarter ended September 30, 2020 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
|
|
(1) |
the Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
|
|
(2) |
the information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company. |
|
Date: November 2, 2020 |
By: |
|
/s/ Stephen Furlong |
|
|
Name: |
|
Stephen Furlong |
|
|
Title: |
|
VP, Finance, Chief Financial Officer and Member of the Office of the President(Principal Financial and Accounting Officer)
|